NCT07675681 REmote Virtual Inspiration: Vitality and Energy
| NCT ID | NCT07675681 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arizona State University |
| Condition | Implementation Science |
| Study Type | INTERVENTIONAL |
| Enrollment | 280 participants |
| Start Date | 2026-07 |
| Primary Completion | 2029-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 280 participants in total. It began in 2026-07 with a primary completion date of 2029-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
REVIVE is a randomized controlled trial designed to evaluate the effects of a remotely delivered seated Tai Chi/Qigong (TCQ) intervention on cardiometabolic health, stress, sleep, and psychological well-being among women with mobility impairments. Women with mobility impairments experience higher rates of obesity, cardiometabolic disease, chronic stress, sleep disturbances, and mental health concerns compared with women without disabilities. Limited access to accessible physical activity programs and barriers to participation in traditional exercise interventions contribute to these health disparities. Tai Chi and Qigong are gentle mind-body practices that may improve physical and psychological health through movement, breathing, and mindfulness techniques and can be adapted for individuals with limited mobility. Participants will be randomized to either a seated Tai Chi/Qigong intervention or a health education video control condition. During the 12-week intervention phase, participants will receive daily video-based content delivered remotely. Participants assigned to the Tai Chi/Qigong group will engage in seated meditative movement practices, while participants assigned to the control group will receive health and wellness education videos unrelated to physical activity or nutrition behavior change. Outcomes will be assessed remotely at baseline, post-intervention, and follow-up. Primary outcomes include waist circumference and indicators of physiological stress regulation, including heart rate variability and salivary cortisol. Secondary outcomes include perceived stress, emotion regulation, depression, anxiety, emotional eating, sleep quality, and sleep disturbance. Additional measures collected through wearable technology, sleep diaries, questionnaires, and biological samples will be used to examine potential behavioral, psychological, and physiological mechanisms underlying intervention effects. The findings from this study will contribute to the development of accessible, scalable, and evidence-based health promotion interventions designed to improve cardiometabolic health and overall well-being among women with mobility impairments.
Eligibility Criteria
Inclusion Criteria: * Self-identify as a woman. * Age 35-64 years. * Mobility impairment lasting at least 1 year. * Regular use of a mobility aid (e.g., wheelchair, scooter, walker, cane, crutches, or other assistive device). * Community dwelling. * Able to demonstrate sufficient upper-extremity mobility to participate in seated Tai Chi/Qigong activities. * Access to a smartphone, tablet, or computer with internet access. * Willing to wear a study-provided wearable device and complete study assessments. * Reside in the United States. * Waist circumference ≥ 33 inches (84 cm). * Perceived Stress Scale (PSS) score ≥ 15. * Insomnia Severity Index (ISI) score ≥ 8. * Emotional eating indicated by a score \< 3 on the Mindful Eating Questionnaire (MEQ) Emotional Response subscale. * Able to understand written and spoken English. * Able to provide informed consent. * Able to provide healthcare provider approval for participation. Exclusion Criteria: * Medical conditions that would make participation unsafe, as determined during screening. * Inability to safely perform seated upper-body movements. * Current participation in a structured Tai Chi, Qigong, or similar meditative movement program. * Pregnancy, lactation, or plans to become pregnant during the study period. * Cognitive, visual, auditory, or other impairments that would preclude completion of study procedures. * Implanted cardiac devices or implanted electronic devices that interfere with physiologic measurements. * Severe arrhythmia, left ventricular assist device (LVAD), or other conditions that interfere with heart rate variability assessment. * Use of sleep medications three or more times per week. * Medical conditions or medications that substantially affect autonomic nervous system activity, sleep, or stress-related outcomes. * Uncontrolled cardiovascular, neurological, psychiatric, or other serious medical conditions that would preclude safe participation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07675681 clinical trial?
This trial is open to female participants only, aged 35 Years or older, up to 64 Years, studying Implementation Science. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07675681 currently recruiting?
Yes, NCT07675681 is actively recruiting participants. Contact the research team at releephd@yahoo.com for enrollment information.
Where is the NCT07675681 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT07675681 clinical trial?
NCT07675681 is sponsored by Arizona State University. The trial plans to enroll 280 participants.